Compare Moderna, Inc. (MRNA) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs PepsiCo, Inc. — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while PepsiCo, Inc. trades at $134.75 (market cap $184.89B). The key difference: PepsiCo, Inc. is far larger — about 7.8× Moderna, Inc.'s market cap, and PepsiCo, Inc. pays a 4.37% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | PEP | |
|---|---|---|
Market Cap | $23.60B | $184.89B |
Sector | Health | Consumer Staples |
52-Week High | $81.80 | $170.44 |
52-Week Low | $22.36 | $135.40 |
Enterprise Value | $19.70B | $227.39B |
Dividend Yield | — | 4.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PepsiCo (PEP) trades at $134.98, down 1.56% over 24 hours, with a bearish technical signal and support near $130. The company reported revenue of $93.93B in 2025 and has beaten EPS estimates in recent quarters. Analysts maintain a consensus price target of $158.50, with 33% buy ratings. Recent news highlights price cuts on snacks like Doritos to address consumer pushback on high prices.
PEP offers a stable dividend and strong profitability with a 10.78% net margin, but faces risks from inflation and competitive pressures. The stock's current valuation below consensus target suggests potential upside if North American performance improves, though near-term technical weakness may persist.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
